戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 thers had scarring of the eyelid margins and blepharitis.
2  the dominant ophthalmic disease followed by blepharitis.
3 ike condition, characterized by alopecia and blepharitis.
4  dysfunction (MGD), a common form of chronic blepharitis.
5 various forms of dry eye, MG dysfunction and blepharitis.
6 ididymal fat pads, and a tendency to develop blepharitis.
7    Fourteen patients had chalazia and 10 had blepharitis.
8 irus in the skin is a determining factor for blepharitis.
9 symptom ratings and a clinician diagnosis of blepharitis.
10 treatment cannot be recommended for treating blepharitis.
11 reatment for patients grappling with Demodex blepharitis.
12 ising drug in treating patients with Demodex blepharitis.
13 ce of Demodex species can be associated with blepharitis.
14 junctivitis, meibomian gland dysfunction and blepharitis.
15 acy of lotilaner in the treatment of Demodex blepharitis.
16 y eye syndrome (2%), conjunctivitis (0.87%), blepharitis (0.51%), anterior uveitis (0.39%), and kerat
17 ignificantly lower than in the patients with blepharitis (14.6 mOsm/L [95% CI, 12.5-17.5]; P = .006)
18                    Out of 2542 patients with blepharitis, 197 patients (315 eyes) were identified wit
19 %), corneal scarring (26%), ectropion (25%), blepharitis (23%), conjunctival melanosis (20%), and cat
20 ularization (6.00 vs. 0.75; p < 0.0001), and blepharitis (3.11 vs. 2.06; p = 0.001) compared to the L
21 ratoconjunctivitis sicca (11.3%) followed by blepharitis (3.2%), molluscum contagiosum (2.6%), conjun
22 oped conjunctivitis 126 (39.5%), followed by blepharitis 47 (14.73%), and dacryocystitis 45 (14.1%).
23  mites in individuals suffering from Demodex blepharitis according to RR for the intervention versus
24                                    Eyes with blepharitis and autoimmune disease improved less than av
25                                              Blepharitis and clinical signs of infection were evident
26              Sixteen patients with posterior blepharitis and conjunctival inflammation due to MGD wer
27  simplex virus type 1 (HSV-1) causes chronic blepharitis and conjunctivitis as well as keratitis in h
28 3) > 80% showed ocular surface inflammation (blepharitis and conjunctivitis) when housed in a standar
29 SVJ129 background, which show development of blepharitis and conjunctivitis.
30 splay a marked propensity for development of blepharitis and conjunctivitis.
31 -1alpha and matrix metalloproteinases in the blepharitis and corneal epitheliopathy, respectively.
32 cal trigeminal ganglion and reduced herpetic blepharitis and corneal scarring.
33                       The high prevalence of blepharitis and dry eye highlights the importance of oph
34 nificantly more susceptible to HSV-1-induced blepharitis and encephalitis.
35         The 5gP DNA-vaccinated mice had less blepharitis and latency than any other group and had the
36  lid margin, suggesting a pathogenic role in blepharitis and meibomian gland dysfunction.
37  repeated measurements between patients with blepharitis and patients with SS was not identified (P =
38  with an atopic phenotype that manifested as blepharitis and pulmonary inflammation with a high level
39 shared common features including preexisting blepharitis and the lack of a Tenon's flap.
40    There was, however, significantly reduced blepharitis and viral replication within the periocular
41 ample (18 patients with SS, 11 patients with blepharitis, and 8 control participants) who were evalua
42 Osm/L, 304 mOsm/L, and 301 mOsm/L in the SS, blepharitis, and control groups, respectively (P = .46).
43 nocytophaga infections, including keratitis, blepharitis, and endophthalmitis, can lead to severe eye
44 ificant corneal opacity, neovascularization, blepharitis, and epitheliopathy were observed in naive o
45  prevalence of DED, allergic conjunctivitis, blepharitis, and glaucoma was below the global average,
46  eye disease (DED), allergic conjunctivitis, blepharitis, and glaucoma were quite low compared with t
47         Both mouse models showed dermatitis, blepharitis, and splenomegaly.
48 sustained below the target pressure, chronic blepharitis, and the presence of punctal plugs.
49 factors for symptomatic improvement included blepharitis, autoimmune disease and ocular allergies.
50 eral treatments have been in use for Demodex blepharitis, before the discovery of lotilaner, like tea
51 tion should raise the possibility of Demodex blepharitis being considered by ophthalmologists in pati
52 junctivitis, meibomian gland dysfunction and blepharitis, between patients with psoriasis and without
53 ements in patients with SS and patients with blepharitis compared with control participants.
54 dary end points for the treatment of Demodex blepharitis compared with vehicle control.
55 ) PFU of vaccinia virus strain WR results in blepharitis, corneal neovascularization, and stromal ker
56 ogies involving meibomian gland dysfunction, blepharitis, corneal or conjunctival defects.
57 strain McKrae, virus replication in the eye, blepharitis, corneal scarring, and dermatitis were deter
58 rae, virus replication in the eye, survival, blepharitis, corneal scarring, and latency were determin
59 lly located bleb; presence of a high bleb or blepharitis; development of a late-onset bleb leak; use
60  were more likely to completely resolve than blepharitis episodes (p = 0.03).
61 r risk factor, the most common of which were blepharitis in 12 (30.8%), dry eyes in 12 (30.8%), and h
62 sions on the eyelids in 55% of the patients, blepharitis in 44%, conjunctival hyperemia in 28%, and s
63 ge depletion, however, resulted in increased blepharitis in immunized mice.
64 acy against HSV-1 replication in the eye and blepharitis in infected mice.
65          NFAT mutant mice also have allergic blepharitis, interstitial pneumonitis, and a 10(3) to 10
66                                              Blepharitis is a chronic inflammatory condition of the e
67 nic biofilms from the eyelid margin to treat blepharitis long-term.
68 uce grossly visible auricular dermatitis and blepharitis, mediated by ZIKV-specific CD8+ T cells.
69 ar and limbal redness, tear volume, anterior blepharitis, meibomian gland capping) and tear inflammat
70       Its clinical spectrum includes chronic blepharitis, meibomitis, conjunctivitis, and corneal inv
71                                              Blepharitis occurred in 37% and minor corneal epitheliop
72 sfunction (OR: 4.45, 95% CI: 1.9-10.40), and blepharitis (OR: 2.28, 95% CI: 1.24-4.19).
73 odex colonization does not necessarily cause blepharitis, our findings of increased colonization shou
74 ntrolled trial, 42 patients with symptomatic blepharitis refractory to treatment were assigned to the
75 occus pyogenes and Pseudomonas aeruginosa in blepharitis; Staphylococci, Streptococus pneumoniae, Pse
76                In addition to conjunctivitis/blepharitis, the de novo appearance of head/neck dermati
77  require extra lubrication and management of blepharitis to prevent epithelial toxicity at the time o
78  but may involve inflammation extending from blepharitis to the conjunctiva.
79 proteasome inhibitor associated chalazia and blepharitis, to investigate outcomes of different manage
80                        Patients with Demodex blepharitis treated at 21 United States clinical sites w
81    Four hundred twelve patients with Demodex blepharitis were assigned randomly in a 1:1 ratio to rec
82      Most patients with SS and patients with blepharitis were taking systemic or topical dry eye medi
83 xteen patients found to have chalazia and/or blepharitis while receiving proteasome inhibitors for pl
84 ely downregulated in dry eye syndrome and in blepharitis, yet little information is available about n